Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05933304 · ClinicalTrials.gov registry record
A Study of the Effectiveness of Moderna COVID-19 Vaccine
A clinical trial, sponsored by ModernaTX.
- Completed
- Registry status
- 927,004
- Enrollment target
NCT05933304: Completed study, sponsored by ModernaTX.
NCT05933304 is a clinical trial that has completed, run by ModernaTX. The registered enrollment target is 927,004 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05933304 has completed, sponsored by ModernaTX.
- COMPLETED
- Registry status
- 927,004 participants
- Enrollment target
Study Summary
This is an observational cohort study to evaluate real-world vaccine effectiveness and durability of Moderna COVID-19 vaccine among a diverse population at Kaiser Permanente Southern California (KPSC). The primary objective of this study is to evaluate the vaccine effectiveness (VE) of receipt of Moderna COVID-19 vaccine in preventing SARS-CoV-2 infection and severe COVID-19 disease. SARS-CoV-2 infection will be defined as a positive antigen test result as well as a positive molecular diagnostic test among symptomatic or asymptomatic participants or a COVID-19 diagnosis code. Severe COVID-19 disease will be defined as COVID-19 hospitalization or mortality.
Primary Outcome
SARS-CoV-2 infection is defined as a positive antigen test result as well as a positive molecular test or a COVID-19 diagnosis code.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 927,004 participants |
| Start Date | 2020-12-18 |
| Est. Completion | 2023-11-17 |
What the finished NCT05933304 record still lists
NCT05933304 is an observational study that tracks outcomes without assigning an intervention. Its 927,004 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT05933304 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05933304 about?
NCT05933304 is a clinical study titled "A Study of the Effectiveness of Moderna COVID-19 Vaccine". This is an observational cohort study to evaluate real-world vaccine effectiveness and durability of Moderna COVID-19 vaccine among a diverse population at Kaiser Permanente Southern California (KPSC). The primary objective of this study is to evaluate the vaccine effectiveness (VE) of receipt of M...
What is the current status of trial NCT05933304?
This trial is currently completed. The enrollment target is 927,004 participants. The study started on 2020-12-18. Estimated completion is 2023-11-17.
Who is sponsoring clinical trial NCT05933304?
This trial is sponsored by ModernaTX, which has 90 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01073475 · 950,000 participants
Maternal Newborn Health Registry
- NCT06029933 · 960,000 participants
Fluad vs. Fluzone High-Dose Vaccine Effectiveness Among Adults ≥65 Years
- NCT05066763 · 1,000,000 participants
Parkinson's Foundation Surveys
- NCT07075341 · 1,000,000 participants
Healthy Living BEYOND Weight Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI